AI in Diagnostics Market Likely to Surpass USD 14.3 Billion by 2035

Buy Now

A significant study discovering the market avenues on, “AI in Diagnostics Market Size, Share & Trends Analysis Report by Technology Type (Machine Learning, Deep Learning, Natural Language Processing (NLP), Computer Vision, Predictive Analytics, Neural Networks, Context-Aware Processing, Others), Diagnostic Type, Deployment Mode, Component, Imaging Modality, Application, Organization Size, Data Type, End-users, and Geography (North America, Europe, Asia Pacific, Middle East, Africa, and South America) – Global Industry Data, Trends, and Forecasts, 2025–2035” A holistic view of the market pathways in the AI in diagnostics market underscores revenue acceleration through scalable product line extensions, high‑maturity strategic partnerships.

Global AI in Diagnostics Market Forecast 2035:

According to the report, the global AI in diagnostics market is likely to grow from USD 2.6 Billion in 2025 to USD 14.3 Billion in 2035 at a highest CAGR of 18.6% during the time period. AI in Diagnostics market is rapidly changing the nature of healthcare, where artificial intelligence is applied to enhance disease detection, diagnosis, and patient management in the fields of radiology, pathology, genomics, and laboratory testing. The AIs allow medical information to be interpreted quicker and more precisely, workflow optimized, and predictive analysis, which can help to intervene early and provide treatment to individuals.

The most popular segment is radiology because of AI-assisted imaging applications, but pathology and genomics are also now adopting AI to process tissues and interpret complicated genetic information automatically. The major growth enablers are the growing need of early and accurate diagnosis, the growing R&D efforts of healthcare and technology firms, and the embrace and use of platform-based solutions like Philips HealthSuite Digital Platform and AI-driven devices offered by GE HealthCare. North America is a leading part with well-established health care infrastructure, regulations, and the level of technology uptake. Predictive diagnostics, cloud-based platforms and strategic alliances are among the market trends that can be used to speed up AI implementation, but issues like regulatory compliance, privacy of data and integrating AI into clinical work processes still exist.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global AI in Diagnostics Market

The development of telemedicine and digital healthcare platforms contributes to the AI in diagnostics market as it allows analyzing medical images, lab tests, and genomic data remotely to provide faster and accurate care. An example is the use of AI in Philips HealthSuite Digital Platform, which is used to aid in virtual patient monitoring and diagnostics within healthcare networks.

Lack of standard data formats, communication protocols and integration frameworks across health care systems discourage the expansion of AI in the diagnostics market. Artificial intelligence (AI) technologies tend to have difficulties accessing and processing data across various electronic health records (EHR) systems, imaging machines, and lab systems and are less efficient and accurate. Such disintegration may slow down the process of clinical decision-making and impede the implementation of AI solutions in large scale.

The increased use of platform-based AI solutions is an opportunity to unite diagnostic tools in the healthcare systems, facilitate remote patient monitoring, and provide telemedicine services. These systems make accessibility easier, minimize and speed up diagnostic delays, and enable clinicians to make faster and more data-driven decisions. An example is Cedars-Sinab Connect (CS Connect), an AI-based virtual care assistant designed together with digital health company K Health. Released in 2023, CS Connect is an automated patient intake, symptom evaluation, and treatment recommendation system based on a chatbot interface.

Expansion of Global AI in Diagnostics Market

“Innovation, and public funding propels the global AI in Diagnostics market expansion”

The AI in diagnostics market of the world is growing because of the ongoing innovation in AI algorithms, imaging technologies, and predictive analytics is fueling the growth of the global AI in diagnostics market. For instance, benchmarked against New England Journal of Medicine (NEJM) case records, Microsoft’s AI Diagnostic Orchestrator (MAI-DxO) achieves up to 85% diagnostic accuracy, over four times higher than experienced physicians, while reducing costs. With rising healthcare demand and barriers to timely care, digital AI tools are increasingly used for medical advice, with Microsoft’s AI products like Bing and Copilot handling over 50 million health-related sessions daily, from routine queries to urgent-care guidance.
The government encouragement and academic-industry partnerships are rapidly expanding the AI in diagnostics market, especially in North America. For instance, the U.S. Department of Health and Human Services doubled funding for the Childhood Cancer Data Initiative at the National Cancer Institute from $50 million to $100 million to accelerate AI-driven diagnostic and treatment development.

Regional Analysis of Global AI in Diagnostics Market

The AI in Diagnostics market is most demanded in North America due to the combination of robust healthcare infrastructure, high levels of technology adoption, and favorable regulatory systems, which provide a perfect environment in which AI-based diagnostic systems can thrive. Hospitals and clinics are integrating AI to conduct imaging, lab and genomic analysis, and telemedicine and remote monitoring are further increasing access to care, which drives the demand. Remarkable examples are Philips HealthSuite Digital Platform, which allows remote diagnostics and predictive analytics powered by AI over healthcare networks, and GE HealthCare AI-enabled radiology equipment, used to simplify radiology and enhance the precision of the diagnosis. These examples show that the progressive ecosystem in North America is a stimulus to AI diagnostics adoption and innovation.
The fastest growth is predicted in the AI of diagnostics of the Asia Pacific market because of the fast modernization of the scientific facilities, the development of the pharmaceutical research and development and the increase in investments on the high-tech AI platform on the medical care and diagnostics. China and other countries like Japan and India are also improving by investing in digital healthcare infrastructure, AI research and regulatory frameworks that can support innovative diagnostic solutions. As an instance, in 2025, AIIMS Patna, together with the Ministry of Health and Family Welfare in India, implemented AI-powered imaging devices to facilitate the diagnostics of cancer, heart, and neurological diseases, making it more accurate and efficient in terms of X-rays, MRI, and CT scans.

Prominent players operating in the global AI in diagnostics market are Aidoc Medical Ltd., Arterys Inc., Butterfly Network, Inc., Enlitic, Inc., Freenome Holdings, Inc., GE Healthcare, Google Health, HeartFlow, Inc., IBM Watson Health, iCAD, Inc., Intel Corporation, Lunit Inc., Microsoft Healthcare, NVIDIA Corporation, Paige.AI, PathAI, Inc., Philips Healthcare, Qure.ai, RADLogics, Inc., Siemens Healthineers AG, Tempus Labs, Inc., Viz.ai, Inc., Zebra Medical Vision, and and Other Key Players.

The global AI in Diagnostics market has been segmented as follows:

Global AI in Diagnostics Market Analysis, By Technology Type

Machine Learning
Deep Learning
Natural Language Processing (NLP)
Computer Vision
Predictive Analytics
Neural Networks
Context-Aware Processing
Others

Global AI in Diagnostics Market Analysis, By Diagnostic Type

Radiology Diagnostics
Pathology Diagnostics
Cardiology Diagnostics
Oncology Diagnostics
Neurology Diagnostics
Ophthalmology Diagnostics
Dermatology Diagnostics
Genomics Diagnostics
Others

Global AI in Diagnostics Market Analysis, By Deployment Mode

Cloud-Based
On-Premises
Hybrid

Global AI in Diagnostics Market Analysis, By Component

Software
Hardware
Services

Global AI in Diagnostics Market Analysis, By Imaging Modality

CT Scans
MRI
X-Ray
Ultrasound
PET Scans
Mammography
Histopathology Imaging
Others

Global AI in Diagnostics Market Analysis, By Application

Disease Diagnosis
Risk Assessment
Treatment Planning
Drug Discovery
Clinical Decision Support
Patient Monitoring
Medical Imaging Analysis
Predictive Diagnostics
Others

Global AI in Diagnostics Market Analysis, By Organization Size

Large Enterprises
Small and Medium Enterprises (SMEs)

Global AI in Diagnostics Market Analysis, By Data Type

Structured Data
Unstructured Data
Semi-Structured Data

Global AI in Diagnostics Market Analysis, By End-users

Hospitals
- Emergency Diagnostics
- Inpatient Diagnostics
- Outpatient Diagnostics
- ICU Monitoring
- Surgical Planning
- Others
Diagnostic Imaging Centers
- Radiology Image Analysis
- Screening Programs
- Second Opinion Services
- Quantitative Imaging
- Others
Diagnostic Laboratories
- Pathology Analysis
- Blood Test Interpretation
- Molecular Diagnostics
- Microbiology Analysis
- Others
Research & Academic Institutes
- Clinical Trial Support
- Biomarker Discovery
- Disease Modeling
- Educational Training
- Others
Pharmaceutical & Biotechnology Companies
- Drug Development
- Clinical Trial Optimization
- Companion Diagnostics
- Pharmacogenomics
- Others
Ambulatory Surgical Centers
- Pre-operative Assessment
- Post-operative Monitoring
- Point-of-Care Diagnostics
- Others
Telemedicine Providers
- Remote Diagnostics
- Virtual Consultations
- Home Health Monitoring
- Mobile Health Applications
- Others

Global AI in Diagnostics Market Analysis, by Region

North America
Europe
Asia Pacific
Middle East
Africa
South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
  - 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
  - 1.6.1. Open Sources
  - 1.6.2. Paid Databases
  - 1.6.3. Associations
- 1.7. Primary Research
  - 1.7.1. Primary Sources
  - 1.7.2. Primary Interviews with Stakeholders across Ecosystem
2. Executive Summary
- 2.1. Global AI in Diagnostics Market Outlook
  - 2.1.1. AI in Diagnostics Market Size (Value - US$ Bn), and Forecasts, 2021-2035
  - 2.1.2. Compounded Annual Growth Rate Analysis
  - 2.1.3. Growth Opportunity Analysis
  - 2.1.4. Segmental Share Analysis
  - 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
  - 2.5.1. Customer/ End-use Industry Assessment
  - 2.5.2. Growth Opportunity Data, 2025-2035
    - 2.5.2.1. Regional Data
    - 2.5.2.2. Country Data
    - 2.5.2.3. Segmental Data
  - 2.5.3. Identification of Potential Market Spaces
  - 2.5.4. GAP Analysis
  - 2.5.5. Potential Attractive Price Points
  - 2.5.6. Prevailing Market Risks & Challenges
  - 2.5.7. Preferred Sales & Marketing Strategies
  - 2.5.8. Key Recommendations and Analysis
  - 2.5.9. A Way Forward
3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
  - 3.1.1. Healthcare & PharmaceuticalIndustry Ecosystem Analysis
  - 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
  - 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.4. Trade Analysis
  - 3.4.1. Import & Export Analysis, 2025
  - 3.4.2. Top Importing Countries
  - 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
  - 3.5.1. Manufacturer
    - 3.5.1.1. Based on the component & Raw material
  - 3.5.2. Supply Chain
  - 3.5.3. End Consumer
- 3.6. Raw Material Analysis
4. Market Overview
- 4.1. Market Dynamics
  - 4.1.1. Drivers
    - 4.1.1.1. Rapid advances in machine-learning/deep-learning for imaging and diagnostics
    - 4.1.1.2. Rising prevalence of chronic diseases and greater screening demand
    - 4.1.1.3. Healthcare digitization (EHRs, digital pathology, telemedicine) and increased investment
  - 4.1.2. Restraints
    - 4.1.2.1. Data privacy, security and regulatory compliance hurdles.
    - 4.1.2.2. Limited clinical validation, reimbursement uncertainty and liability concerns
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
  - 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
  - 4.3.2. Tariffs and Standards
  - 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
- 4.5. Porter’s Five Forces Analysis
- 4.6. PESTEL Analysis
- 4.7. Global AI in Diagnostics Market Demand
  - 4.7.1. Historical Market Size - in Value (US$ Bn), 2020-2024
  - 4.7.2. Current and Future Market Size - Value (US$ Bn), 2025–2035
    - 4.7.2.1. Y-o-Y Growth Trends
    - 4.7.2.2. Absolute $ Opportunity Assessment
5. Competition Landscape
- 5.1. Competition structure
  - 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
  - 5.2.1. Global Company Market Share
  - 5.2.2. By Region
    - 5.2.2.1. North America
    - 5.2.2.2. Europe
    - 5.2.2.3. Asia Pacific
    - 5.2.2.4. Middle East
    - 5.2.2.5. Africa
    - 5.2.2.6. South America
- 5.3. Product Comparison Matrix
  - 5.3.1. Specifications
  - 5.3.2. Market Positioning
  - 5.3.3. Pricing
6. Global AI in Diagnostics Market Analysis, By Technology Type
- 6.1. Key Segment Analysis
- 6.2. AI in Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, By Technology Type, 2021-2035
  - 6.2.1. Machine Learning
  - 6.2.2. Deep Learning
  - 6.2.3. Natural Language Processing (NLP)
  - 6.2.4. Computer Vision
  - 6.2.5. Predictive Analytics
  - 6.2.6. Neural Networks
  - 6.2.7. Context-Aware Processing
  - 6.2.8. Others
7. Global AI in Diagnostics Market Analysis, By Diagnostic Type
- 7.1. Key Segment Analysis
- 7.2. AI in Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, By Diagnostic Type, 2021-2035
  - 7.2.1. Radiology Diagnostics
  - 7.2.2. Pathology Diagnostics
  - 7.2.3. Cardiology Diagnostics
  - 7.2.4. Oncology Diagnostics
  - 7.2.5. Neurology Diagnostics
  - 7.2.6. Ophthalmology Diagnostics
  - 7.2.7. Dermatology Diagnostics
  - 7.2.8. Genomics Diagnostics
  - 7.2.9. Others
8. Global AI in Diagnostics Market Analysis and Forecasts, By Deployment Mode
- 8.1. Key Findings
- 8.2. AI in Diagnostics Market Size (Value - US$ Mn), Analysis, and Forecasts, By Deployment Mode, 2021-2035
  - 8.2.1. Cloud-Based
  - 8.2.2. On-Premises
  - 8.2.3. Hybrid
9. Global AI in Diagnostics Market Analysis and Forecasts, By Component
- 9.1. Key Findings
- 9.2. AI in Diagnostics Market Size (Value - US$ Mn), Analysis, and Forecasts, By Component, 2021-2035
  - 9.2.1. Software
  - 9.2.2. Hardware
  - 9.2.3. Services
10. Global AI in Diagnostics Market Analysis and Forecasts, By Imaging Modality
- 10.1. Key Findings
- 10.2. AI in Diagnostics Market Size (Value - US$ Mn), Analysis, and Forecasts, By Imaging Modality, 2021-2035
  - 10.2.1. CT Scans
  - 10.2.2. MRI
  - 10.2.3. X-Ray
  - 10.2.4. Ultrasound
  - 10.2.5. PET Scans
  - 10.2.6. Mammography
  - 10.2.7. Histopathology Imaging
  - 10.2.8. Others
11. Global AI in Diagnostics Market Analysis and Forecasts, By Application
- 11.1. Key Findings
- 11.2. AI in Diagnostics Market Size (Value - US$ Mn), Analysis, and Forecasts, By Application, 2021-2035
  - 11.2.1. Disease Diagnosis
  - 11.2.2. Risk Assessment
  - 11.2.3. Treatment Planning
  - 11.2.4. Drug Discovery
  - 11.2.5. Clinical Decision Support
  - 11.2.6. Patient Monitoring
  - 11.2.7. Medical Imaging Analysis
  - 11.2.8. Predictive Diagnostics
  - 11.2.9. Others
12. Global AI in Diagnostics Market Analysis and Forecasts, By Organization Size
- 12.1. Key Findings
- 12.2. AI in Diagnostics Market Size (Value - US$ Mn), Analysis, and Forecasts, By Organization Size, 2021-2035
  - 12.2.1. Large Enterprises
  - 12.2.2. Small and Medium Enterprises (SMEs)
13. Global AI in Diagnostics Market Analysis and Forecasts, By Data Type
- 13.1. Key Findings
- 13.2. AI in Diagnostics Market Size (Volume - Million Units and Value - US$ Mn), Analysis, and Forecasts, By Data Type, 2021-2035
  - 13.2.1. Structured Data
  - 13.2.2. Unstructured Data
  - 13.2.3. Semi-Structured Data
14. Global AI in Diagnostics Market Analysis and Forecasts, By End-users
- 14.1. Key Findings
- 14.2. AI in Diagnostics Market Size (Value - US$ Mn), Analysis, and Forecasts, By End-users, 2021-2035
  - 14.2.1. Hospitals
    - 14.2.1.1. Emergency Diagnostics
    - 14.2.1.2. Inpatient Diagnostics
    - 14.2.1.3. Outpatient Diagnostics
    - 14.2.1.4. ICU Monitoring
    - 14.2.1.5. Surgical Planning
    - 14.2.1.6. Others
  - 14.2.2. Diagnostic Imaging Centers
    - 14.2.2.1. Radiology Image Analysis
    - 14.2.2.2. Screening Programs
    - 14.2.2.3. Second Opinion Services
    - 14.2.2.4. Quantitative Imaging
    - 14.2.2.5. Others
  - 14.2.3. Diagnostic Laboratories
    - 14.2.3.1. Pathology Analysis
    - 14.2.3.2. Blood Test Interpretation
    - 14.2.3.3. Molecular Diagnostics
    - 14.2.3.4. Microbiology Analysis
    - 14.2.3.5. Others
  - 14.2.4. Research & Academic Institutes
    - 14.2.4.1. Clinical Trial Support
    - 14.2.4.2. Biomarker Discovery
    - 14.2.4.3. Disease Modeling
    - 14.2.4.4. Educational Training
    - 14.2.4.5. Others
  - 14.2.5. Pharmaceutical & Biotechnology Companies
    - 14.2.5.1. Drug Development
    - 14.2.5.2. Clinical Trial Optimization
    - 14.2.5.3. Companion Diagnostics
    - 14.2.5.4. Pharmacogenomics
    - 14.2.5.5. Others
  - 14.2.6. Ambulatory Surgical Centers
    - 14.2.6.1. Pre-operative Assessment
    - 14.2.6.2. Post-operative Monitoring
    - 14.2.6.3. Point-of-Care Diagnostics
    - 14.2.6.4. Others
  - 14.2.7. Telemedicine Providers
    - 14.2.7.1. Remote Diagnostics
    - 14.2.7.2. Virtual Consultations
    - 14.2.7.3. Home Health Monitoring
    - 14.2.7.4. Mobile Health Applications
    - 14.2.7.5. Others
15. Global AI in Diagnostics Market Analysis and Forecasts, by Region
- 15.1. Key Findings
- 15.2. AI in Diagnostics Market Size (Value - US$ Mn), Analysis, and Forecasts, by Region, 2021-2035
  - 15.2.1. North America
  - 15.2.2. Europe
  - 15.2.3. Asia Pacific
  - 15.2.4. Middle East
  - 15.2.5. Africa
  - 15.2.6. South America
16. North America AI in Diagnostics Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. North America AI in Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 16.3.1. Technology Type
  - 16.3.2. Diagnostic Type
  - 16.3.3. Deployment Mode
  - 16.3.4. Component
  - 16.3.5. Imaging Modality
  - 16.3.6. Application
  - 16.3.7. Organization Size
  - 16.3.8. Data Type
  - 16.3.9. End-Users
  - 16.3.10. Country
    - 16.3.10.1. USA
    - 16.3.10.2. Canada
    - 16.3.10.3. Mexico
- 16.4. USA AI in Diagnostics Market
  - 16.4.1. Country Segmental Analysis
  - 16.4.2. Technology Type
  - 16.4.3. Diagnostic Type
  - 16.4.4. Deployment Mode
  - 16.4.5. Component
  - 16.4.6. Imaging Modality
  - 16.4.7. Application
  - 16.4.8. Organization Size
  - 16.4.9. Data Type
  - 16.4.10. End-Users
- 16.5. Canada AI in Diagnostics Market
  - 16.5.1. Technology Type
  - 16.5.2. Diagnostic Type
  - 16.5.3. Deployment Mode
  - 16.5.4. Component
  - 16.5.5. Imaging Modality
  - 16.5.6. Application
  - 16.5.7. Organization Size
  - 16.5.8. Data Type
  - 16.5.9. End-Users
- 16.6. Mexico AI in Diagnostics Market
  - 16.6.1. Country Segmental Analysis
  - 16.6.2. Technology Type
  - 16.6.3. Diagnostic Type
  - 16.6.4. Deployment Mode
  - 16.6.5. Component
  - 16.6.6. Imaging Modality
  - 16.6.7. Application
  - 16.6.8. Organization Size
  - 16.6.9. Data Type
  - 16.6.10. End-Users
17. Europe AI in Diagnostics Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Europe AI in Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 17.3.1. Technology Type
  - 17.3.2. Diagnostic Type
  - 17.3.3. Deployment Mode
  - 17.3.4. Component
  - 17.3.5. Imaging Modality
  - 17.3.6. Application
  - 17.3.7. Organization Size
  - 17.3.8. Data Type
  - 17.3.9. End-Users
  - 17.3.10. Country
    - 17.3.10.1. Germany
    - 17.3.10.2. United Kingdom
    - 17.3.10.3. France
    - 17.3.10.4. Italy
    - 17.3.10.5. Spain
    - 17.3.10.6. Netherlands
    - 17.3.10.7. Nordic Countries
    - 17.3.10.8. Poland
    - 17.3.10.9. Russia & CIS
    - 17.3.10.10. Rest of Europe
- 17.4. Germany AI in Diagnostics Market
  - 17.4.1. Country Segmental Analysis
  - 17.4.2. Technology Type
  - 17.4.3. Diagnostic Type
  - 17.4.4. Deployment Mode
  - 17.4.5. Component
  - 17.4.6. Imaging Modality
  - 17.4.7. Application
  - 17.4.8. Organization Size
  - 17.4.9. Data Type
  - 17.4.10. End-Users
- 17.5. United Kingdom AI in Diagnostics Market
  - 17.5.1. Country Segmental Analysis
  - 17.5.2. Technology Type
  - 17.5.3. Diagnostic Type
  - 17.5.4. Deployment Mode
  - 17.5.5. Component
  - 17.5.6. Imaging Modality
  - 17.5.7. Application
  - 17.5.8. Organization Size
  - 17.5.9. Data Type
  - 17.5.10. End-Users
- 17.6. France AI in Diagnostics Market
  - 17.6.1. Country Segmental Analysis
  - 17.6.2. Technology Type
  - 17.6.3. Diagnostic Type
  - 17.6.4. Deployment Mode
  - 17.6.5. Component
  - 17.6.6. Imaging Modality
  - 17.6.7. Application
  - 17.6.8. Organization Size
  - 17.6.9. Data Type
  - 17.6.10. End-Users
- 17.7. Italy AI in Diagnostics Market
  - 17.7.1. Country Segmental Analysis
  - 17.7.2. Technology Type
  - 17.7.3. Diagnostic Type
  - 17.7.4. Deployment Mode
  - 17.7.5. Component
  - 17.7.6. Imaging Modality
  - 17.7.7. Application
  - 17.7.8. Organization Size
  - 17.7.9. Data Type
  - 17.7.10. End-Users
- 17.8. Spain AI in Diagnostics Market
  - 17.8.1. Country Segmental Analysis
  - 17.8.2. Technology Type
  - 17.8.3. Diagnostic Type
  - 17.8.4. Deployment Mode
  - 17.8.5. Component
  - 17.8.6. Imaging Modality
  - 17.8.7. Application
  - 17.8.8. Organization Size
  - 17.8.9. Data Type
  - 17.8.10. End-Users
- 17.9. Netherlands AI in Diagnostics Market
  - 17.9.1. Country Segmental Analysis
  - 17.9.2. Technology Type
  - 17.9.3. Diagnostic Type
  - 17.9.4. Deployment Mode
  - 17.9.5. Component
  - 17.9.6. Imaging Modality
  - 17.9.7. Application
  - 17.9.8. Organization Size
  - 17.9.9. Data Type
  - 17.9.10. End-Users
- 17.10. Nordic Countries AI in Diagnostics Market
  - 17.10.1. Country Segmental Analysis
  - 17.10.2. Technology Type
  - 17.10.3. Diagnostic Type
  - 17.10.4. Deployment Mode
  - 17.10.5. Component
  - 17.10.6. Imaging Modality
  - 17.10.7. Application
  - 17.10.8. Organization Size
  - 17.10.9. Data Type
  - 17.10.10. End-Users
- 17.11. Poland AI in Diagnostics Market
  - 17.11.1. Country Segmental Analysis
  - 17.11.2. Technology Type
  - 17.11.3. Diagnostic Type
  - 17.11.4. Deployment Mode
  - 17.11.5. Component
  - 17.11.6. Imaging Modality
  - 17.11.7. Application
  - 17.11.8. Organization Size
  - 17.11.9. Data Type
  - 17.11.10. End-Users
- 17.12. Russia & CIS AI in Diagnostics Market
  - 17.12.1. Country Segmental Analysis
  - 17.12.2. Technology Type
  - 17.12.3. Diagnostic Type
  - 17.12.4. Deployment Mode
  - 17.12.5. Component
  - 17.12.6. Imaging Modality
  - 17.12.7. Application
  - 17.12.8. Organization Size
  - 17.12.9. Data Type
  - 17.12.10. End-Users
- 17.13. Rest of Europe AI in Diagnostics Market
  - 17.13.1. Country Segmental Analysis
  - 17.13.2. Technology Type
  - 17.13.3. Diagnostic Type
  - 17.13.4. Deployment Mode
  - 17.13.5. Component
  - 17.13.6. Imaging Modality
  - 17.13.7. Application
  - 17.13.8. Organization Size
  - 17.13.9. Data Type
  - 17.13.10. End-Users
18. Asia Pacific AI in Diagnostics Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. East Asia AI in Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 18.3.1. Technology Type
  - 18.3.2. Diagnostic Type
  - 18.3.3. Deployment Mode
  - 18.3.4. Component
  - 18.3.5. Imaging Modality
  - 18.3.6. Application
  - 18.3.7. Organization Size
  - 18.3.8. Data Type
  - 18.3.9. End-Users
  - 18.3.10. Country
    - 18.3.10.1. China
    - 18.3.10.2. India
    - 18.3.10.3. Japan
    - 18.3.10.4. South Korea
    - 18.3.10.5. Australia and New Zealand
    - 18.3.10.6. Indonesia
    - 18.3.10.7. Malaysia
    - 18.3.10.8. Thailand
    - 18.3.10.9. Vietnam
    - 18.3.10.10. Rest of Asia Pacific
- 18.4. China AI in Diagnostics Market
  - 18.4.1. Country Segmental Analysis
  - 18.4.2. Technology Type
  - 18.4.3. Diagnostic Type
  - 18.4.4. Deployment Mode
  - 18.4.5. Component
  - 18.4.6. Imaging Modality
  - 18.4.7. Application
  - 18.4.8. Organization Size
  - 18.4.9. Data Type
  - 18.4.10. End-Users
- 18.5. India AI in Diagnostics Market
  - 18.5.1. Country Segmental Analysis
  - 18.5.2. Technology Type
  - 18.5.3. Diagnostic Type
  - 18.5.4. Deployment Mode
  - 18.5.5. Component
  - 18.5.6. Imaging Modality
  - 18.5.7. Application
  - 18.5.8. Organization Size
  - 18.5.9. Data Type
  - 18.5.10. End-Users
- 18.6. Japan AI in Diagnostics Market
  - 18.6.1. Country Segmental Analysis
  - 18.6.2. Technology Type
  - 18.6.3. Diagnostic Type
  - 18.6.4. Deployment Mode
  - 18.6.5. Component
  - 18.6.6. Imaging Modality
  - 18.6.7. Application
  - 18.6.8. Organization Size
  - 18.6.9. Data Type
  - 18.6.10. End-Users
- 18.7. South Korea AI in Diagnostics Market
  - 18.7.1. Country Segmental Analysis
  - 18.7.2. Technology Type
  - 18.7.3. Diagnostic Type
  - 18.7.4. Deployment Mode
  - 18.7.5. Component
  - 18.7.6. Imaging Modality
  - 18.7.7. Application
  - 18.7.8. Organization Size
  - 18.7.9. Data Type
  - 18.7.10. End-Users
- 18.8. Australia and New Zealand AI in Diagnostics Market
  - 18.8.1. Country Segmental Analysis
  - 18.8.2. Technology Type
  - 18.8.3. Diagnostic Type
  - 18.8.4. Deployment Mode
  - 18.8.5. Component
  - 18.8.6. Imaging Modality
  - 18.8.7. Application
  - 18.8.8. Organization Size
  - 18.8.9. Data Type
  - 18.8.10. End-Users
- 18.9. Indonesia AI in Diagnostics Market
  - 18.9.1. Country Segmental Analysis
  - 18.9.2. Technology Type
  - 18.9.3. Diagnostic Type
  - 18.9.4. Deployment Mode
  - 18.9.5. Component
  - 18.9.6. Imaging Modality
  - 18.9.7. Application
  - 18.9.8. Organization Size
  - 18.9.9. Data Type
  - 18.9.10. End-Users
- 18.10. Malaysia AI in Diagnostics Market
  - 18.10.1. Country Segmental Analysis
  - 18.10.2. Technology Type
  - 18.10.3. Diagnostic Type
  - 18.10.4. Deployment Mode
  - 18.10.5. Component
  - 18.10.6. Imaging Modality
  - 18.10.7. Application
  - 18.10.8. Organization Size
  - 18.10.9. Data Type
  - 18.10.10. End-Users
- 18.11. Thailand AI in Diagnostics Market
  - 18.11.1. Country Segmental Analysis
  - 18.11.2. Technology Type
  - 18.11.3. Diagnostic Type
  - 18.11.4. Deployment Mode
  - 18.11.5. Component
  - 18.11.6. Imaging Modality
  - 18.11.7. Application
  - 18.11.8. Organization Size
  - 18.11.9. Data Type
  - 18.11.10. End-Users
- 18.12. Vietnam AI in Diagnostics Market
  - 18.12.1. Country Segmental Analysis
  - 18.12.2. Technology Type
  - 18.12.3. Diagnostic Type
  - 18.12.4. Deployment Mode
  - 18.12.5. Component
  - 18.12.6. Imaging Modality
  - 18.12.7. Application
  - 18.12.8. Organization Size
  - 18.12.9. Data Type
  - 18.12.10. End-Users
- 18.13. Rest of Asia Pacific AI in Diagnostics Market
  - 18.13.1. Country Segmental Analysis
  - 18.13.2. Technology Type
  - 18.13.3. Diagnostic Type
  - 18.13.4. Deployment Mode
  - 18.13.5. Component
  - 18.13.6. Imaging Modality
  - 18.13.7. Application
  - 18.13.8. Organization Size
  - 18.13.9. Data Type
  - 18.13.10. End-Users
19. Middle East AI in Diagnostics Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. Middle East AI in Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 19.3.1. Technology Type
  - 19.3.2. Diagnostic Type
  - 19.3.3. Deployment Mode
  - 19.3.4. Component
  - 19.3.5. Imaging Modality
  - 19.3.6. Application
  - 19.3.7. Organization Size
  - 19.3.8. Data Type
  - 19.3.9. End-Users
  - 19.3.10. Country
    - 19.3.10.1. Turkey
    - 19.3.10.2. UAE
    - 19.3.10.3. Saudi Arabia
    - 19.3.10.4. Israel
    - 19.3.10.5. Rest of Middle East
- 19.4. Turkey AI in Diagnostics Market
  - 19.4.1. Country Segmental Analysis
  - 19.4.2. Technology Type
  - 19.4.3. Diagnostic Type
  - 19.4.4. Deployment Mode
  - 19.4.5. Component
  - 19.4.6. Imaging Modality
  - 19.4.7. Application
  - 19.4.8. Organization Size
  - 19.4.9. Data Type
  - 19.4.10. End-Users
- 19.5. UAE AI in Diagnostics Market
  - 19.5.1. Country Segmental Analysis
  - 19.5.2. Technology Type
  - 19.5.3. Diagnostic Type
  - 19.5.4. Deployment Mode
  - 19.5.5. Component
  - 19.5.6. Imaging Modality
  - 19.5.7. Application
  - 19.5.8. Organization Size
  - 19.5.9. Data Type
  - 19.5.10. End-Users
- 19.6. Saudi Arabia AI in Diagnostics Market
  - 19.6.1. Country Segmental Analysis
  - 19.6.2. Technology Type
  - 19.6.3. Diagnostic Type
  - 19.6.4. Deployment Mode
  - 19.6.5. Component
  - 19.6.6. Imaging Modality
  - 19.6.7. Application
  - 19.6.8. Organization Size
  - 19.6.9. Data Type
  - 19.6.10. End-Users
- 19.7. Israel AI in Diagnostics Market
  - 19.7.1. Country Segmental Analysis
  - 19.7.2. Technology Type
  - 19.7.3. Diagnostic Type
  - 19.7.4. Deployment Mode
  - 19.7.5. Component
  - 19.7.6. Imaging Modality
  - 19.7.7. Application
  - 19.7.8. Organization Size
  - 19.7.9. Data Type
  - 19.7.10. End-Users
- 19.8. Rest of Middle East AI in Diagnostics Market
  - 19.8.1. Country Segmental Analysis
  - 19.8.2. Technology Type
  - 19.8.3. Diagnostic Type
  - 19.8.4. Deployment Mode
  - 19.8.5. Component
  - 19.8.6. Imaging Modality
  - 19.8.7. Application
  - 19.8.8. Organization Size
  - 19.8.9. Data Type
  - 19.8.10. End-Users
20. Africa AI in Diagnostics Market Analysis
- 20.1. Key Segment Analysis
- 20.2. Regional Snapshot
- 20.3. Africa AI in Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 20.3.1. Technology Type
  - 20.3.2. Diagnostic Type
  - 20.3.3. Deployment Mode
  - 20.3.4. Component
  - 20.3.5. Imaging Modality
  - 20.3.6. Application
  - 20.3.7. Organization Size
  - 20.3.8. Data Type
  - 20.3.9. End-Users
  - 20.3.10. Country
    - 20.3.10.1. South Africa
    - 20.3.10.2. Egypt
    - 20.3.10.3. Nigeria
    - 20.3.10.4. Algeria
    - 20.3.10.5. Rest of Africa
- 20.4. South Africa AI in Diagnostics Market
  - 20.4.1. Country Segmental Analysis
  - 20.4.2. Technology Type
  - 20.4.3. Diagnostic Type
  - 20.4.4. Deployment Mode
  - 20.4.5. Component
  - 20.4.6. Imaging Modality
  - 20.4.7. Application
  - 20.4.8. Organization Size
  - 20.4.9. Data Type
  - 20.4.10. End-Users
- 20.5. Egypt AI in Diagnostics Market
  - 20.5.1. Country Segmental Analysis
  - 20.5.2. Technology Type
  - 20.5.3. Diagnostic Type
  - 20.5.4. Deployment Mode
  - 20.5.5. Component
  - 20.5.6. Imaging Modality
  - 20.5.7. Application
  - 20.5.8. Organization Size
  - 20.5.9. Data Type
  - 20.5.10. End-Users
- 20.6. Nigeria AI in Diagnostics Market
  - 20.6.1. Country Segmental Analysis
  - 20.6.2. Technology Type
  - 20.6.3. Diagnostic Type
  - 20.6.4. Deployment Mode
  - 20.6.5. Component
  - 20.6.6. Imaging Modality
  - 20.6.7. Application
  - 20.6.8. Organization Size
  - 20.6.9. Data Type
  - 20.6.10. End-Users
- 20.7. Algeria AI in Diagnostics Market
  - 20.7.1. Country Segmental Analysis
  - 20.7.2. Technology Type
  - 20.7.3. Diagnostic Type
  - 20.7.4. Deployment Mode
  - 20.7.5. Component
  - 20.7.6. Imaging Modality
  - 20.7.7. Application
  - 20.7.8. Organization Size
  - 20.7.9. Data Type
  - 20.7.10. End-Users
- 20.8. Rest of Africa AI in Diagnostics Market
  - 20.8.1. Country Segmental Analysis
  - 20.8.2. Technology Type
  - 20.8.3. Diagnostic Type
  - 20.8.4. Deployment Mode
  - 20.8.5. Component
  - 20.8.6. Imaging Modality
  - 20.8.7. Application
  - 20.8.8. Organization Size
  - 20.8.9. Data Type
  - 20.8.10. End-Users
21. South America AI in Diagnostics Market Analysis
- 21.1. Key Segment Analysis
- 21.2. Regional Snapshot
- 21.3. Central and South Africa AI in Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 21.3.1. Technology Type
  - 21.3.2. Diagnostic Type
  - 21.3.3. Deployment Mode
  - 21.3.4. Component
  - 21.3.5. Imaging Modality
  - 21.3.6. Application
  - 21.3.7. Organization Size
  - 21.3.8. Data Type
  - 21.3.9. End-Users
  - 21.3.10. Country
    - 21.3.10.1. Brazil
    - 21.3.10.2. Argentina
    - 21.3.10.3. Rest of South America
- 21.4. Brazil AI in Diagnostics Market
  - 21.4.1. Country Segmental Analysis
  - 21.4.2. Technology Type
  - 21.4.3. Diagnostic Type
  - 21.4.4. Deployment Mode
  - 21.4.5. Component
  - 21.4.6. Imaging Modality
  - 21.4.7. Application
  - 21.4.8. Organization Size
  - 21.4.9. Data Type
  - 21.4.10. End-Users
- 21.5. Argentina AI in Diagnostics Market
  - 21.5.1. Country Segmental Analysis
  - 21.5.2. Technology Type
  - 21.5.3. Diagnostic Type
  - 21.5.4. Deployment Mode
  - 21.5.5. Component
  - 21.5.6. Imaging Modality
  - 21.5.7. Application
  - 21.5.8. Organization Size
  - 21.5.9. Data Type
  - 21.5.10. End-Users
- 21.6. Rest of South America AI in Diagnostics Market
  - 21.6.1. Country Segmental Analysis
  - 21.6.2. Technology Type
  - 21.6.3. Diagnostic Type
  - 21.6.4. Deployment Mode
  - 21.6.5. Component
  - 21.6.6. Imaging Modality
  - 21.6.7. Application
  - 21.6.8. Organization Size
  - 21.6.9. Data Type
  - 21.6.10. End-Users
22. Key Players/ Company Profile
- 22.1. Aidoc Medical Ltd.
  - 22.1.1. Company Details/ Overview
  - 22.1.2. Company Financials
  - 22.1.3. Key Customers and Competitors
  - 22.1.4. Business/ Industry Portfolio
  - 22.1.5. Product Portfolio/ Specification Details
  - 22.1.6. Pricing Data
  - 22.1.7. Strategic Overview
  - 22.1.8. Recent Developments
- 22.2. Arterys Inc.
- 22.3. Butterfly Network, Inc.
- 22.4. Enlitic, Inc.
- 22.5. Freenome Holdings, Inc.
- 22.6. GE Healthcare
- 22.7. Google Health
- 22.8. HeartFlow, Inc.
- 22.9. IBM Watson Health
- 22.10. iCAD, Inc.
- 22.11. Intel Corporation
- 22.12. Lunit Inc.
- 22.13. Microsoft Healthcare
- 22.14. NVIDIA Corporation
- 22.15. Paige.AI
- 22.16. PathAI, Inc.
- 22.17. Philips Healthcare
- 22.18. Qure.ai
- 22.19. RADLogics, Inc.
- 22.20. Siemens Healthineers AG
- 22.21. Tempus Labs, Inc.
- 22.22. Viz.ai, Inc.
- 22.23. Zebra Medical Vision
- 22.24. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF

PRICING DETAILS

Single-User Upto 2 Users - [PDF + Excel Only]

USD 4150

Multi-User Upto 10 Users - [PDF + Excel + PPT]

USD 5950

Enterprise-User Company-wide - [Report Pack + Benchmark + 6M Update]

USD 7750

Related Report

Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation